The Novel Electrolyzed Water Spray Treatment Discomfort, Redness and Swelling of the Skin Surrounding the Wound
A Novel Electrolyzed Water Spray Reduces Discomfort, Redness and Swelling of the Skin Surrounding the Wound Created by Skin Lasar Surgery: A Clinical Study
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to test whether the reduction of the sense of discomfort and redness and swelling of the skin surrounding the wound of patients by use of the novel electrolyzed water spray will relieve the inflammation of the skin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2023
CompletedFirst Submitted
Initial submission to the registry
February 27, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2024
CompletedApril 25, 2024
February 1, 2023
6 months
February 27, 2023
April 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The sense of discomfort scale made by the Numeric Pain Rating Scale (NPRS).
This score is based on descriptions of the discomfort of the skin surrounding the wound that patients rate 0-10 to assess the condition of their skin. A higher score means a worse outcome. 0 means "no discomfort " and 10 means "the most discomfort ".
1 hour
Secondary Outcomes (1)
A skin signs scale made by modifying the Numeric Pain Rating Scale (NPRS).
3 hour
Study Arms (2)
The electrolyzed water spray group
EXPERIMENTALStudy staff will use the novel electrolyzed water spray device and spray for approximately 2-4 minutes on the participant's diseased area until half a bottle (20-40ml) of water is used.
Control group of water spray
PLACEBO COMPARATORStudy staff will use the saline and spray for approximately 2-4 minutes on the participant's diseased area until half a bottle (20-40ml) of water is used.
Interventions
The researcher use electrolyzed water to treat the diseased area, two times a day, for 5 days. The trial consists of 5 study visits (day 1-day 5). The reduction in the disease area of discomfort, redness and swelling evaluation and adverse event assessments will be performed at each visit. Safety analysis will be assessed based on the reports of adverse events during the study.
The researcher use saline to treat the diseased area, two times a day, for 5 days. The trial consists of 5 study visits (day 1-day 5). The reduction in the disease area of discomfort, redness and swelling evaluation and adverse event assessments will be performed at each visit. Safety analysis will be assessed based on the reports of adverse events during the study.
Eligibility Criteria
You may qualify if:
- Mild discomfort, redness and swelling of the skin surrounding the wound created by skin laser surgery
- Patient \> 18 years old.
You may not qualify if:
- Severe discomfort, redness and swelling of the skin surrounding the wound created by skin laser surgery.
- years or older.
- Pregnant or breastfeeding women
- Systemically healthy individuals.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Huinuode Biotechnology Co., Ltd.
Qingdao, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2023
First Posted
March 31, 2023
Study Start
January 29, 2023
Primary Completion
July 15, 2023
Study Completion
March 10, 2024
Last Updated
April 25, 2024
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- until publication of this clinical study and international patent granted